The Impact of Symptom Burden on Patient Quality of Life in Chronic Myeloid Leukemia

Publisher： Karger

E-ISSN： 1423-0232|87|3|133-147

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.3, 2014-07, pp. : 133-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-08 ,pp. : 105-109

Karger

Access to resources Recommend Favorite

Imatinib‐induced psoriasiform eruption in a patient with chronic myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 467-468

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overcoming resistance in chronic myeloid leukemia

By Roy Rupali   Talpaz Moshe  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 817-821

Future Science

Access to resources Recommend Favorite

HAUSP compartmentalization in chronic myeloid leukemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 4, 2015-04 ,pp. : 318-321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dasatinib in the Treatment of Chronic Myeloid Leukemia

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 1, 2011-01 ,pp. : 99-105

Bentham Science Publishers

Access to resources Recommend Favorite